InVitro International Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	0.81	0.79	0.85	1	1.1
Revenue Growth (YoY)	2.35%	-7.13%	-14.94%	-9.18%	4.95%
Cost of Revenue	0.16	0.16	0.17	0.2	0.21
Gross Profit	0.65	0.64	0.68	0.8	0.9
Selling, General & Admin	0.53	0.65	0.71	0.72	0.8
Research & Development	0.05	0.01	0.09	0.11	0.07
Operating Expenses	0.59	0.66	0.8	0.83	0.87
Operating Income	0.07	-0.03	-0.12	-0.03	0.03
Interest & Investment Income	0.04	0.03	0.01	0.01	0.02
Other Non Operating Income (Expenses)	-	-	0.11	-	-
EBT Excluding Unusual Items	0.11	0	0	-0.02	0.05
Gain (Loss) on Sale of Investments	-	-	-0.09	0.01	0.01
Other Unusual Items	-	-	0.1	0.11	-
Pretax Income	0.11	0	0.01	0.11	0.06
Income Tax Expense	-	0	-0.01	0.01	0.01
Net Income	0.11	0	0.02	0.1	0.05
Net Income to Common	0.11	0	0.02	0.1	0.05
Net Income Growth	6770.83%	-92.70%	-77.84%	92.39%	-29.40%
Shares Outstanding (Basic)	23	23	23	23	23
Shares Outstanding (Diluted)	24	24	23	23	23
Shares Change (YoY)	-0.15%	1.98%	0.87%	2.10%	2.91%
EPS (Basic)	0.00	0.00	0.00	0.00	0.00
EPS (Diluted)	0.00	0.00	0.00	0.00	0.00
EPS Growth	6053.85%	-93.07%	-76.54%	100.05%	-33.37%
Free Cash Flow	0.1	-0.06	0.03	0.03	-0.02
Free Cash Flow Per Share	0.00	-0.00	0.00	0.00	-0.00
Gross Margin	80.55%	80.24%	79.69%	80.15%	81.24%
Operating Margin	8.42%	-3.20%	-13.68%	-2.67%	2.83%
Profit Margin	13.15%	0.20%	2.49%	9.57%	4.52%
Free Cash Flow Margin	12.15%	-7.56%	3.66%	2.88%	-2.02%
EBITDA	0.07	-0.02	-0.11	-0.03	0.03
EBITDA Margin	8.96%	-2.77%	-13.34%	-2.49%	3.10%
D&A For EBITDA	0	0	0	0	0
EBIT	0.07	-0.03	-0.12	-0.03	0.03
EBIT Margin	8.42%	-3.20%	-13.68%	-2.67%	2.83%
Effective Tax Rate	-	34.00%	-	9.01%	18.79%
Advertising Expenses	0.04	0.02	0.07	-	0.09